Ivan Papic

Zagreb, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use.

Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use.

Journal: Journal of psychopharmacology (Oxford, England)

Published: March 14, 2024

Patterns of corticosteroid use among remdesivir and matched patients and associated clinical outcomes in hospitalized COVID-19 patients.

Patterns of corticosteroid use among remdesivir and matched patients and associated clinical outcomes in hospitalized COVID-19 patients.

Journal: Expert opinion on pharmacotherapy

Published: February 16, 2024

Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients.

Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients.

Journal: Viruses

Published: November 30, 2023

Duration of corticosteroid treatment in hospitalized COVID-19 patients, less is more.

Duration of corticosteroid treatment in hospitalized COVID-19 patients, less is more.

Journal: The Korean journal of internal medicine

Published: October 21, 2023

Negative Prognostic Associations of Selective Serotonin Reuptake Inhibitors Use in Hospitalized COVID-19 Patients and Potential Contribution of Cardiovascular Comorbidities.

Negative Prognostic Associations of Selective Serotonin Reuptake Inhibitors Use in Hospitalized COVID-19 Patients and Potential Contribution of Cardiovascular Comorbidities.

Journal: Pharmacology

Published: September 20, 2023

Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry.

Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry.

Journal: Croatian medical journal

Published: January 04, 2023

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis.

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis.

Journal: The American journal of emergency medicine

Published: April 26, 2022

Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.

Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.

Journal: The Journal of infection

Published: April 23, 2022

The associations of age, sex, and comorbidities with survival of hospitalized patients with coronavirus disease 2019: data from 4014 patients from a tertiary-center registry.

The associations of age, sex, and comorbidities with survival of hospitalized patients with coronavirus disease 2019: data from 4014 patients from a tertiary-center registry.

Journal: Croatian medical journal

Published: March 01, 2022

Impact of an integrated medication reconciliation model led by a hospital clinical pharmacist on the reduction of post-discharge unintentional discrepancies.

Impact of an integrated medication reconciliation model led by a hospital clinical pharmacist on the reduction of post-discharge unintentional discrepancies.

Journal: Journal of clinical pharmacy and therapeutics

Published: March 11, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026